Schwartz Jeffrey Lawrence 4
4 · SpringWorks Therapeutics, Inc. · Filed Mar 20, 2023
Insider Transaction Report
Form 4
Schwartz Jeffrey Lawrence
Director10% Owner
Transactions
- Sale
Common Stock
2023-03-16$28.50/sh−1,750,000$49,875,000→ 3,081,307 total(indirect: See footnote)
Holdings
- 5,924
Common Stock
Footnotes (1)
- [F1]Consists of shares of common stock held directly by BC SW, LP. Bain Capital Life Sciences Investors, LLC ("BCLSI") is the general partner of BC SW, LP. Mr. Schwartz is a Partner of BCLSI. As a result, Mr. Schwartz may be deemed to share voting and dispositive power with respect to the shares of common stock held by BC SW, LP. Mr. Schwartz disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.